The MEA radiotherapy market will reach with a CAGR of 5.6% in the forecast period of 2018 to 2025.

The major factors contributing to the growth of the market Includes factors such as the rising Incidence of cancer, Increasing acceptance of adaptive radiation therapy (ART), growing pool of geriatric population and Increasing number of cancer treatment facilities. On the other hand, high cost of radiotherapy equipment and lack of skilled professionals hampering the growth of the market.
Market Segmentation for MEA Radiotherapy Market
The market is further segmented into;
Therapy Type
Product type
Application
The MEA radiotherapy market is segmented on the basis of product into therapy type, product type and application. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.
On the basis of therapy type, the MEA radiotherapy market is segmented into beam radiotherapy, brachytherapy and systemic radiotherapy. The beam radiotherapy is further sub-segmented into IGRT, IMRT, VMAT, Tomotherapy, stereotactic technology and 3D conformal radiotherapy. The Brachytherapy is further sub-segmented into LDR and HDR. In 2018, beam radiotherapy is expected to dominate the MEA radiotherapy market with 79.5% market share and is expected to reach, with the CAGR of 5.5% in the forecast period 2018 to 2025. However, systemic radiotherapy segment is expected to grow at the highest CAGR 8.8% and was valued at.
On the basis of product type, the MEA radiotherapy market is segmented into external beam radiotherapy, internal radiotherapy products, radiotherapy software and systemic radiotherapy. The external beam radiotherapy is further sub-segmented into LINAC, cyber knife, proton therapy and gamma knife. The proton therapy is further sub segmented into cyclotron and synclotron. The Internal beam is further sub-segmented into seeds and after loaders. The Radiotherapy Software segment is further sub-segmented into treatment planning software, dosage planning software, patient positioning software and image guiding software. In 2018, external beam radiotherapy is expected to dominate the MEA radiotherapy market with, with the CAGR of 5.2% in the forecast period 2018 to 2025. However, systemic radiotherapy segment is expected to grow at the highest CAGR 11.4% and was valued.
On the basis of application, the MEA radiotherapy market is segmented type into prostate cancer, breast cancer, lung cancer, spine cancer, liver cancer, brain cancer and others. In 2018, Prostate Cancer is expected to dominate the MEA radiotherapy market with 36.3% market share and is expected to reach
Based on geography, the MEA radiotherapy market is segmented into,
South Africa
Egypt
Saudi Arabia
United Arab Emirates
Israel
Rest of Middle East & Africa
Key Market Players for MEA Radiotherapy Market

Elekta
Varian Medical Systems Inc.
Accuray
Mevion Medical Systems
Brainlab Ag
Ion Beam Applications Sa
Isoray Medical, Inc.
Nanobiotix
Nordion (Canada) Inc.
Precisis AG
Raysearch Laboratories Ab
Recent Developments in the market
? In September 2018, ELEKTA AB (Sweden), announced an agreement with the Siriraj Hospital (Thailand) for advanced radiotherapy technology. The acquisition is the part of a major radiotherapy which will expand the department enabling Siriraj Hospital clinicians to treat their cancer patients more effectively.
? In August 2018, Varian Medical Systems, Inc.(U.S.) the acquisition of privately-held humediQ Global GmbH, for radiation therapy. This acquisition expands Varian's motion-management portfolio and is a part of the company's long-term growth and value creation strategy.

Key Takeaways
Some of the major factors driving the market for MEA radiotherapy are
? The rising Incidence of cancer, Increasing acceptance of adaptive radiation therapy (ART),
Growing pool of geriatric population and Increasing number of cancer treatment facilities.
? High cost of radiotherapy equipment and lack of skilled professionals hampering the growth of the market.


Key factors of the report
The report covers the present scenario and the growth prospects of the MEA radiotherapy market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.